Lanzatech co-founder: we are missing out on the synthetic biology revolution

Lanzatech co-founder: we are missing out on the synthetic biology revolution
Dr Sean Simpson. (Image: Getty)
Peter Griffin
The third New Zealand-founded company in as many years is set to list on the Nasdaq.LanzaTech’s merger with “blank cheque” Nasdaq-listed company AMCI Acquisition Corp II sees it follow in the footsteps of Rocket Lab and footwear maker All Birds in taking the special purpose acquisition company (SPAC) route to become a publicly traded company.The deal, which values the merged company at around US$1.8 billion (NZ$2.8b), was cleared by shareholders on Tuesday. It confirms the Illinois-based LanzaTech’s status as our mo...

More Opinion

Putting some PEP into the investment PIE
Opinion

Paul McBeth: Putting some PEP into the investment PIE

The Australian private equity giant is offering investors a gateway into its world.

How NZ stacks up in the climate credibility test
Opinion

Dileepa Fonseka: How NZ stacks up in the climate credibility test

The Govt needs something bold to firmly establish its credibility on climate change.

Dileepa Fonseka 22 Jul 2024
On track: Understanding rail investment
Opinion

Simon Robertson: On track: Understanding rail investment

Radically changing the railroad business model the Hunter Harrison way.

Simon Robertson 20 Jul 2024